Acibadem Healthcare Group
Seda Aras Gürcan
Pediatric Hematologist

Seda Aras Gürcan

Medical Units and Clinical Services
  • Pediatric Hematology and Oncology
  • Pediatrics

M.D. Seda Aras Gürcan is a pediatric hematologist-oncologist affiliated with Acıbadem Health Group. She completed her pediatric hematology and oncology training at Marmara University Faculty of Medicine in 2023. Dr. Gürcan is an active member of several professional organizations, including the Turkish Pediatric Hematology Association, Turkish Hematology Association, Turkish Pediatric Association and its Young Pediatricians group, the Turkish Pediatric Oncology Society, the Istanbul Medical Chamber, and the European Hematology Association (EHA). Her clinical focus includes diagnosis and treatment of blood disorders and cancers in children, with a commitment to evidence-based care and compassionate family-centered practice. She stays engaged with the pediatric and hematology communities through professional memberships and ongoing collaboration with peers in Turkey and Europe.

Education

  • 2023 Marmara University Faculty of Medicine Pediatric Hematology and Oncology
  • 2016 Marmara University Faculty of Medicine Pediatrics
  • 2009 Hacettepe University Faculty of Medicine

Experience

  • 2025 Acibadem Health Group
  • 2023 – 2025 Hatay Training and Research Hospital / Pediatric Hematology and Oncology / Subspecialty / State Service Obligation
  • 2019 – 2023 Marmara University Pendik Training and Research Hospital Pediatric Hematology and Oncology / Subspecialty Assistant Doctor
  • 2016 – 2019 Agri State Hospital Okmeydanı Training and Research Hospital / Specialist Doctor
  • 2011 – 2016 Marmara University Pendik Training and Research Hospital Center for Medical Genetics, Ghent University Hospital, GHENT, BELGIUM (Erasmus Traineeship Program) University of Cologne, Center for Medical Genetics, Cologne, GERMANY (observer) / Assistant Doctor
  • 2009 – 2011 Bartın Health Directorate Bartın Community Health Center Bartın Home Health Services Unit / General Practitioner

Memberships

  • Turkish Pediatric Hematology Association
  • Istanbul Medical Chamber
  • European Hematology Association (EHA)
  • Turkish Hematology Association
  • Turkish Pediatric Association Young Pediatricians
  • Turkish Pediatric Association
  • Turkish Pediatric Oncology Society

Publications

  • Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?.
    Journal of Adolescent and Young Adult Oncology, 11(3), 252-258. Eker, N., Tokuc, A. G., Yılmaz, B., Aktaş, Z., Buğdaycı, O., Erol, B., … & Aras, S.
  • Phenotypic spectrum of BLM and RMI1-related Bloom syndrome.
    Clinical Genetics, 101(5-6), 559-564 Gonenc, I. I., Elcioglu, N. H., Martinez Grijalva, C., Aras, S., Grossmann, N., Praulich, I., … & Wollnik, B.
  • An Astonishing Extrarenal Wilms Localization; Spinal Cord.
    J Pediatr Res 2022;9(2):188-91, DOI: 10.4274/jpr.galenos.2021.34445 Tokuc, A. G., Eker, N., Tas, B. T., Bozkurt, S. U., Sakar, M., Aras, S., & Akar, K. E.
  • COVID?19 infection in children with cancer and stem cell transplant recipients in Turkey: a nationwide study
    Pediatric Blood & Cancer, 68(6), e28915. Kebudi, R., Kurucu, N., Tuğcu, D., Hacısalihoğlu, Ş., Fisgın, T., Ocak, S., Aras S, … & Kara, A.
  • Congenital Severe Factor V Deficiency: Two Cases with Different Clinical Presentations
    Sch J Med Case Rep, March., 2020; 8(3): 424-426 Eker N, Tokuç AG , Yılmaz B, Doğru Ö , Şenay E , Tufan B , Aras S , Koç A
  • Old Friend, Cruel Foe; Theophylline Toxicity: Case Report
    DOI: 10.4274/cayd.galenos.2018.14622 J Pediatr Emerg Intensive Care Med 2020;7:39-43 Kıhtır, H. S., Gör, Z., Aygün, T. E., Çelebi, E., Aras, S., & Kıhtır, Z.
  • Evaluation of Rejection Rates of Samples Arriving from the Pediatric Clinic to the Laboratory: What Should Be Done?
    International Journal of Research Studies in Medical and Health Sciences. 2019; 4(7): 07-10. Dag H, Dikker O, Dag NÇ., Türkkan E, Kaçar A, Aras S.
  • Clinical Importance of Hyponatremia in Pediatric Intensive Care Patients.
    Online Turkish Journal of Health Sciences, 3(4), 206-214. Aygün, F., Aras, S., Varol, F., & Irdem, A.
  • Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.
    J Hum Genet. 2017 Mar;62(3):447-451. doi: 10.1038/jhg.2016.143. Epub 2016 Nov 24. PubMed PMID: 27881841 Guo L, Elcioglu NH, Iida A, Demirkol YK, Aras S, Matsumoto N, Nishimura G, Miyake N, Ikegawa S.




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics